Another rival drug to watch is Byetta, an already approved treatment from Amylin Pharmaceuticals and Eli Lilly.
Reader and biotech investor Matthew Shulman wrote in a several week ago with this question about Amylin Pharmaceuticals.
Upside is possible for Gilead, Genentech and Amylin Pharmaceuticals (nasdaq: AMLN - news - people ).
Six months after a bitter dispute led to an unusual court battle, Eli Lilly and Amylin Pharmaceuticals are getting divorced.
Amylin Pharmaceuticals (AMLN), Xoma (XOMA) and Jazz Pharmaceuticals (JAZZ) are among companies selling stock to raise cash in recent weeks.
Two weeks ago, for instance, Bristol Myers Squibb acquired Amylin Pharmaceuticals (NASDAQ:AMLN), which has won approval for two diabetes drugs, BYETTA and SYMLIN.
Worst hit will be Amylin Pharmaceuticals, which developed Bydureon and its predecessor, the twice-a-day Byetta, from a compound found in Gila monster saliva.
Hecht astutely persuaded Joseph Cook, who had logged 28 years with Eli Lilly and was chairman of Amylin Pharmaceuticals, to serve as chairman.
Worries that Byetta might harm the pancreas have dogged the drug's makers, biotech Amylin Pharmaceuticals and drug giant Eli Lilly, for more than two years.
Amylin Pharmaceuticals , a San Diego-based biotechnology company focused on diabetes, announced that Eli Lilly has signed on to co-promote one of its lead drugs.
The U.S. Food and Drug Administration approved Amylin Pharmaceuticals Inc.
WSJ: FDA Approves Amylin's Bydureon Diabetes Drug After Delays
Amylin Pharmaceuticals (nasdaq: AMLN - news - people ) is in phase III trials of Exenatide, a drug that promises to treat Type 2 diabetes.
When scientists from Amylin Pharmaceuticals saw Eng present his data at a 1996 diabetes conference, they ran for the phones and convinced their bosses to sign a licensing agreement.
Among the largest underlying components of XBI, in trading today Dendreon Corp ( NASD: DNDN) is down about 2.9%, Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is off about 0.1%, and Amylin Pharmaceuticals, Inc. ( NASD: AMLN) is lower by about 1.9%.
Among the largest underlying components of XBI, in trading today Regeneron Pharmaceuticals, Inc. ( NASD: REGN) is up about 2.6%, Amylin Pharmaceuticals, Inc. ( NASD: AMLN) is up about 0.7%, and Medivation Inc ( NASD: MDVN) is lower by about 0.5%.
Nearly two years after the FDA issued what became the first of two rejections, the agency has finally approved the Bydureon diabetes treatment, setting up what is going to be heated battle between Amylin Pharmaceuticals and Novo Nordisk, which sells a rival medicine called Victoza.
FORBES: And They're Off: Amylin And Novo Nordisk Begin Their Battle
应用推荐